• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 Duplex SmartAmp 方法快速检测 MDM2 基因中的 SNP(c.309T>G)。

Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex SmartAmp method.

机构信息

Division of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

出版信息

PLoS One. 2013;8(4):e60151. doi: 10.1371/journal.pone.0060151. Epub 2013 Apr 2.

DOI:10.1371/journal.pone.0060151
PMID:23565197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3614994/
Abstract

BACKGROUND

Genetic polymorphisms in the human MDM2 gene are suggested to be a tumor susceptibility marker and a prognostic factor for cancer. It has been reported that a single nucleotide polymorphism (SNP) c.309T>G in the MDM2 gene attenuates the tumor suppressor activity of p53 and accelerates tumor formation in humans.

METHODOLOGY

In this study, to detect the SNP c.309T>G in the MDM2 gene, we have developed a new SNP detection method, named "Duplex SmartAmp," which enabled us to simultaneously detect both 309T and 309G alleles in one tube. To develop this new method, we introduced new primers i.e., nBP and oBPs, as well as two different fluorescent dyes that separately detect those genetic polymorphisms.

RESULTS AND CONCLUSIONS

By the Duplex SmartAmp method, the genetic polymorphisms of the MDM2 gene were detected directly from a small amount of genomic DNA or blood samples. We used 96 genomic DNA and 24 blood samples to validate the Duplex SmartAmp by comparison with results of the conventional PCR-RFLP method; consequently, the Duplex SmartAmp results agreed totally with those of the PCR-RFLP method. Thus, the new SNP detection method is considered useful for detecting the SNP c.309T>G in the MDM2 gene so as to judge cancer susceptibility against some cellular stress in the clinical setting, and also to handle a large number of samples and enable rapid clinical diagnosis.

摘要

背景

人类 MDM2 基因中的遗传多态性被认为是肿瘤易感性标志物和癌症的预后因素。据报道,MDM2 基因中的单核苷酸多态性 (SNP) c.309T>G 减弱了 p53 的肿瘤抑制活性,并加速了人类肿瘤的形成。

方法

在这项研究中,为了检测 MDM2 基因中的 SNP c.309T>G,我们开发了一种新的 SNP 检测方法,称为“双链 SmartAmp”,它使我们能够在一个管中同时检测 309T 和 309G 等位基因。为了开发这种新方法,我们引入了新的引物 nBP 和 oBPs,以及两种不同的荧光染料,分别检测这些遗传多态性。

结果与结论

通过双链 SmartAmp 方法,可以直接从少量基因组 DNA 或血液样本中检测 MDM2 基因的遗传多态性。我们使用 96 个基因组 DNA 和 24 个血液样本与传统 PCR-RFLP 方法的结果进行比较,验证了双链 SmartAmp;因此,双链 SmartAmp 结果与 PCR-RFLP 方法的结果完全一致。因此,这种新的 SNP 检测方法被认为可用于检测 MDM2 基因中的 SNP c.309T>G,以便在临床环境中判断对某些细胞应激的癌症易感性,同时还可以处理大量样本并实现快速临床诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/bd7551247b09/pone.0060151.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/1f10e66f05be/pone.0060151.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/c20148581e94/pone.0060151.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/cebfc3eb1e91/pone.0060151.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/88e43da5615a/pone.0060151.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/060810615417/pone.0060151.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/bd7551247b09/pone.0060151.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/1f10e66f05be/pone.0060151.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/c20148581e94/pone.0060151.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/cebfc3eb1e91/pone.0060151.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/88e43da5615a/pone.0060151.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/060810615417/pone.0060151.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2507/3614994/bd7551247b09/pone.0060151.g006.jpg

相似文献

1
Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex SmartAmp method.采用 Duplex SmartAmp 方法快速检测 MDM2 基因中的 SNP(c.309T>G)。
PLoS One. 2013;8(4):e60151. doi: 10.1371/journal.pone.0060151. Epub 2013 Apr 2.
2
Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.p53和MDM2基因的多态性与非小细胞肺癌患者的严重毒性相关。
Cancer Biol Ther. 2014;15(11):1542-51. doi: 10.4161/15384047.2014.956599.
3
Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.p53密码子72与MDM2 309T>G多态性之间的相互作用及肝细胞癌风险
Tumour Biol. 2016 Mar;37(3):3863-70. doi: 10.1007/s13277-015-4222-4. Epub 2015 Oct 17.
4
Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid leukemia development.MDM2启动子多态性(-309T>G)在急性髓系白血病发生中的作用。
Asian Pac J Cancer Prev. 2015;16(7):2707-12. doi: 10.7314/apjcp.2015.16.7.2707.
5
Murine double minute clone 2,309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience.小鼠双微体 2,309T/G 和 285G/C 启动子单核苷酸多态性作为乳腺癌的危险因素:波兰的经验。
Int J Biol Markers. 2012 Jul 19;27(2):e105-10. doi: 10.5301/JBM.2012.9140.
6
Association of Mouse Double Minute 2 -309T>G Polymorphism with Acute Myeloid Leukemia in an Iranian Population: A Case- Control Study.伊朗人群中鼠双微体2基因-309T>G多态性与急性髓系白血病的关联:一项病例对照研究
Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3037-3041. doi: 10.31557/APJCP.2019.20.10.3037.
7
Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.MDM2 309T>G(rs2279744) 和 I/D(rs3730485) 多态性及单倍型与甲状腺乳头状癌风险、肿瘤分期、肿瘤大小及发病年龄的关系:病例对照研究。
J Cell Physiol. 2019 Aug;234(8):12934-12940. doi: 10.1002/jcp.27960. Epub 2018 Dec 13.
8
Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.MDM2基因309T>G多态性在Ⅰ期肺腺癌中的预后潜力
Cancer Med. 2016 Aug;5(8):1791-801. doi: 10.1002/cam4.750. Epub 2016 May 26.
9
MDM2 309T>G polymorphism and risk of lung cancer in a Korean population.MDM2基因309T>G多态性与韩国人群肺癌风险
Lung Cancer. 2006 Oct;54(1):19-24. doi: 10.1016/j.lungcan.2006.06.008. Epub 2006 Jul 27.
10
MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.MDM2 启动子 SNP309 与慢性淋巴细胞白血病的易感性增加相关,并与中国 CLL 患者的 MDM2 mRNA 表达相关。
Int J Cancer. 2012 May 1;130(9):2054-61. doi: 10.1002/ijc.26222. Epub 2011 Aug 9.

引用本文的文献

1
SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV.SEB 基因分型:适用于 HBV 的复杂、高度多变目标的 SmartAmp-Eprimer 二进制代码基因分型。
BMC Infect Dis. 2022 Jun 3;22(1):516. doi: 10.1186/s12879-022-07458-4.
2
Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.MDM2基因309T>G多态性在Ⅰ期肺腺癌中的预后潜力
Cancer Med. 2016 Aug;5(8):1791-801. doi: 10.1002/cam4.750. Epub 2016 May 26.
3
Single-nucleotide polymorphism (c.309T>G) in the gene and lung cancer risk.

本文引用的文献

1
Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility.胆管癌易感性中p53及其负调控因子mdm2常见变异的潜在基因型特异性单核苷酸多态性相互作用。
Oncol Lett. 2012 Jul;4(1):101-106. doi: 10.3892/ol.2012.680. Epub 2012 Apr 17.
2
Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis.鼠双微体 2 启动子 SNP309 多态性与前列腺癌风险的关系:一项荟萃分析。
Int J Urol. 2012 Oct;19(10):914-20. doi: 10.1111/j.1442-2042.2012.03067.x. Epub 2012 Jun 21.
3
One-step detection of the 2009 pandemic influenza A(H1N1) virus by the RT-SmartAmp assay and its clinical validation.
该基因中的单核苷酸多态性(c.309T>G)与肺癌风险
Biomed Rep. 2014 Sep;2(5):719-724. doi: 10.3892/br.2014.305. Epub 2014 Jun 26.
4
SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women.NRF2 基因中 ARE-like 区域的 SNP(-617C>A):日本不吸烟女性肺腺癌预后的新生物标志物。
PLoS One. 2013 Sep 11;8(9):e73794. doi: 10.1371/journal.pone.0073794. eCollection 2013.
一步法 RT-SmartAmp 检测试剂盒用于 2009 年甲型 H1N1 流感病毒的检测及其临床验证。
PLoS One. 2012;7(1):e30236. doi: 10.1371/journal.pone.0030236. Epub 2012 Jan 25.
4
MDM2 SNP309 polymorphism and colorectal cancer risk: a meta-analysis.MDM2 SNP309 多态性与结直肠癌风险:荟萃分析。
DNA Cell Biol. 2012 Mar;31(3):355-9. doi: 10.1089/dna.2011.1338. Epub 2011 Jul 19.
5
MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.MDM2 SNP309 多态性与乳腺癌风险的荟萃分析。
Mol Biol Rep. 2012 Apr;39(4):3471-7. doi: 10.1007/s11033-011-1119-1. Epub 2011 Jul 3.
6
Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma.TP53、OGG1、CHRNA3 和 HLA-DQA1 基因对肺鳞癌风险的贡献。
J Thorac Oncol. 2011 Apr;6(4):813-7. doi: 10.1097/JTO.0b013e3181ee80ef.
7
MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.MDM2 SNP309、基因-基因相互作用与肿瘤易感性:一项更新的荟萃分析。
BMC Cancer. 2011 May 29;11:208. doi: 10.1186/1471-2407-11-208.
8
Optimization of turn-back primers in isothermal amplification.回环引物在等温扩增中的优化。
Nucleic Acids Res. 2011 May;39(9):e59. doi: 10.1093/nar/gkr041. Epub 2011 Feb 9.
9
Pharmacogenomics of human ABC transporters: detection of clinically important SNPs by SmartAmp2 method.人类 ABC 转运蛋白的药物基因组学:通过 SmartAmp2 方法检测临床重要的单核苷酸多态性。
Curr Pharm Biotechnol. 2011 Apr;12(4):693-704. doi: 10.2174/138920111795164011.
10
Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1).药物基因组学新兴技术:快速 SNP 检测、分子动力学模拟和 QSAR 分析方法,验证人类 ABC 转运蛋白 ABCB1(P-糖蛋白/MDR1)的临床重要遗传变异。
Pharmacol Ther. 2010 Apr;126(1):69-81. doi: 10.1016/j.pharmthera.2010.01.005. Epub 2010 Feb 4.